person
Jacek S.
- Country
- Poland
- Department
- 40334: Dermatology
Research Overview
assignment
74
Clinical Trials ·
- A Phase 1 Randomized, Double‑Blind, Placebo‑Controlled Study of BBT001 in Healthy Volunteers and Adults with Atopic Dermatitis
- Efficacy and Safety of Zasocitinib in Patients with Moderate to Severe Hidradenitis Suppurativa: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial
- A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Ritlecitinib in Adults with Moderate to Severe Hidradenitis Suppurativa
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
435
Sites with multiple studies
Has run more than one trial at 435 of 736 partner sites.
Specializations
Inflammatory Skin Conditions
Specializes in treating chronic inflammatory skin disorders with particular emphasis on moderate to severe plaque psoriasis and atopic dermatitis.
- Psoriasis management approaches
- Atopic dermatitis interventions
- Hand eczema treatments
Complex Dermatological Conditions
Focuses on challenging skin disorders including hidradenitis suppurativa and prurigo nodularis.
- Hidradenitis suppurativa therapies
- Chronic pruritus management
- Pyoderma gangrenosum treatment
Autoimmune Skin Disorders
Investigates treatments for autoimmune-related skin conditions including lupus erythematosus and bullous pemphigoid.
- Cutaneous lupus treatments
- Alopecia areata interventions
- Urticaria management
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.